Luc G. Berthiaume is a Professor of Cell Biology at the University of Alberta, a role they have held since 2009. Their research focuses on fatty acylation, the covalent attachment of long chain fatty acids to proteins. In 2012, they co-founded Pacylex Pharmaceuticals, Inc. and serves as the Chief Scientific Officer.
Luc G. Berthiaume has a Doctor of Philosophy (Ph.D.) in Biochemistry from Université de Sherbrooke and a Ph.D. in Biochemistry and Molecular Biology from the same university.
August, 2012 - present
Chief Scientific Officer and Co-Founder at Gemphire Therapeutics
Chief Scientific Officer and Co-Founder at OffWorld
Chief Scientific Officer and Co-Founder at Bonumose
Chief Scientific Officer and Co-founder at BOLDSCIENCE
Chief Scientific Officer and Co-Founder at Interface Biosciences